Kainova Therapeutics
Kainova Therapeutics is a biopharmaceutical company located in Strasbourg, France, dedicated to the discovery and early development of small molecules targeting G-coupled Protein Receptors (GPCRs), one of the best classes of drug targets. Domain Therapeutics is using its innovative and proprietary technology platform DTect-All™ to identify orthosteric and allosteric ligands of GPCRs, including the so called Silent Allosteric Modulators (SAMs) that represent a unique source of compounds that cannot be discovered by standard technologies. DTect-All™ is able to address difficult GPCRs such as orphan and peptidic GPCRs.
Domain
domaintherapeutics.com
Country
FranceIndustry
BiotechnologyEmployees
101-250
Last Funding
$23.5M
Founded
2000
Tech Stack (15 technologies)
Frequently Asked Questions
What technologies does Kainova Therapeutics use?+
Kainova Therapeutics uses 15 technologies including Axeptio, Google Analytics, Google Tag Manager.
What industry is Kainova Therapeutics in?+
Kainova Therapeutics operates in the Biotechnology industry.
Where is Kainova Therapeutics based?+
Kainova Therapeutics is headquartered in France.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026